Report cover image

Consumer Health in Latvia

Publisher Euromonitor International
Published Oct 02, 2025
Length 79 Pages
SKU # EP20464037

Description

Consumer health in Latvia is expected to register healthy current value growth in 2025, largely supported by a strong performance in dietary supplements, which is a popular consumer health product. A high incidence of cough and colds is also expected to support value sales, including for analgesics. A degree of premiumisation also supports growth, supported by specialist ingredients and convenient formats.

Euromonitor International's Consumer Health in Latvia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2020-2024, allowing you to identify the sectors driving growth. Forecasts to 2029 illustrate how the market is set to change.

Product coverage: Allergy Care, Herbal/Traditional Products, OTC, Paediatric Consumer Health, Sports Nutrition, Vitamins and Dietary Supplements, Weight Management and Wellbeing.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Consumer Health market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

Table of Contents

79 Pages
Consumer Health in Latvia
Euromonitor International
October 2025
List Of Contents And Tables
CONSUMER HEALTH IN LATVIA
EXECUTIVE SUMMARY
Consumer Health in 2025: The big picture
Key trends in 2025
Competitive landscape
Channel developments
What next for consumer health?
MARKET INDICATORS
Table 1 Consumer Expenditure on Health Goods and Medical Services: Value 2020-2025
Table 2 Life Expectancy at Birth 2020-2025
MARKET DATA
Table 3 Sales of Consumer Health by Category: Value 2020-2025
Table 4 Sales of Consumer Health by Category: % Value Growth 2020-2025
Table 5 NBO Company Shares of Consumer Health: % Value 2021-2025
Table 6 LBN Brand Shares of Consumer Health: % Value 2022-2025
Table 7 Penetration of Private Label by Category: % Value 2020-2025
Table 8 Distribution of Consumer Health by Format: % Value 2020-2025
Table 9 Distribution of Consumer Health by Format and Category: % Value 2025
Table 10 Forecast Sales of Consumer Health by Category: Value 2025-2030
Table 11 Forecast Sales of Consumer Health by Category: % Value Growth 2025-2030
APPENDIX
OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches
DISCLAIMER
DEFINITIONS
SOURCES
Summary 1 Research Sources
ANALGESICS IN LATVIA
KEY DATA FINDINGS
2025 DEVELOPMENTS
Ibuprofen best performer in 2025
Mepha benefits from increasing popularity of topical analgesics
Pharmacies hold a monopoly
PROSPECTS AND OPPORTUNITIES
Slight fall in constant value sales
Increasing demand for more natural offerings
Focus on improving communications, as well as adopting a greener positioning
CATEGORY DATA
Table 12 Sales of Analgesics by Category: Value 2020-2025
Table 13 Sales of Analgesics by Category: % Value Growth 2020-2025
Table 14 NBO Company Shares of Analgesics: % Value 2021-2025
Table 15 LBN Brand Shares of Analgesics: % Value 2022-2025
Table 16 Forecast Sales of Analgesics by Category: Value 2025-2030
Table 17 Forecast Sales of Analgesics by Category: % Value Growth 2025-2030
COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES IN LATVIA
KEY DATA FINDINGS
2025 DEVELOPMENTS
High levels of cough and colds support value sales
Zyrtec benefits from long pollen season
Pharmacies only permitted channel
PROSPECTS AND OPPORTUNITIES
Steady growth over forecast period
E-commerce registers healthy value growth
Further liberalisation could benefit consumers
CATEGORY DATA
Table 18 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2020-2025
Table 19 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2020-2025
Table 20 NBO Company Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2021-2025
Table 21 LBN Brand Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2022-2025
Table 22 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2025-2030
Table 23 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2025-2030
DIGESTIVE REMEDIES IN LATVIA
KEY DATA FINDINGS
2025 DEVELOPMENTS
Healthy value growth in 2025
Rebranded local company Olpha gains most value share
New regulation gives e-commerce a boost
PROSPECTS AND OPPORTUNITIES
Moderate constant value growth over forecast period
Further innovation, with technology playing a key role
Health and wellness trends influence innovation in digestive remedies
CATEGORY DATA
Table 24 Sales of Digestive Remedies by Category: Value 2020-2025
Table 25 Sales of Digestive Remedies by Category: % Value Growth 2020-2025
Table 26 NBO Company Shares of Digestive Remedies: % Value 2021-2025
Table 27 LBN Brand Shares of Digestive Remedies: % Value 2022-2025
Table 28 Forecast Sales of Digestive Remedies by Category: Value 2025-2030
Table 29 Forecast Sales of Digestive Remedies by Category: % Value Growth 2025-2030
DERMATOLOGICALS IN LATVIA
KEY DATA FINDINGS
2025 DEVELOPMENTS
Moderate value growth in 2025
Bayer continues to lead
Pharmacies continue to hold a monopoly
PROSPECTS AND OPPORTUNITIES
Steady growth over forecast period
Digital space increasingly important
Health and wellness trends influence innovation in dermatologicals
CATEGORY DATA
Table 30 Sales of Dermatologicals by Category: Value 2020-2025
Table 31 Sales of Dermatologicals by Category: % Value Growth 2020-2025
Table 32 NBO Company Shares of Dermatologicals: % Value 2021-2025
Table 33 LBN Brand Shares of Dermatologicals: % Value 2022-2025
Table 34 Forecast Sales of Dermatologicals by Category: Value 2025-2030
Table 35 Forecast Sales of Dermatologicals by Category: % Value Growth 2025-2030
WOUND CARE IN LATVIA
KEY DATA FINDINGS
2025 DEVELOPMENTS
Wound care returns to value and volume growth
Local pharmacy chain A Aptiekas, with its private label offering, gains the most value share
Grocery retailers making gains
PROSPECTS AND OPPORTUNITIES
Marginal constant value growth, as maturity and continuing population decline dampens value sales
Continuing innovation over forecast period
Increasing offerings targeted at children
CATEGORY DATA
Table 36 Sales of Wound Care by Category: Value 2020-2025
Table 37 Sales of Wound Care by Category: % Value Growth 2020-2025
Table 38 NBO Company Shares of Wound Care: % Value 2021-2025
Table 39 LBN Brand Shares of Wound Care: % Value 2022-2025
Table 40 Forecast Sales of Wound Care by Category: Value 2025-2030
Table 41 Forecast Sales of Wound Care by Category: % Value Growth 2025-2030
VITAMINS IN LATVIA
KEY DATA FINDINGS
2025 DEVELOPMENTS
Multivitamins register higher value growth in 2025
Global player Axellus holds on to top spot
Value sales increase by a quarter through online channels
PROSPECTS AND OPPORTUNITIES
Positive outlook over forecast period
Continuing innovation and diversification
Compliance, cleaner formualtion and greener positioning key priorities
CATEGORY DATA
Table 42 Sales of Vitamins by Category: Value 2020-2025
Table 43 Sales of Vitamins by Category: % Value Growth 2020-2025
Table 44 Sales of Multivitamins by Positioning: % Value 2020-2025
Table 45 NBO Company Shares of Vitamins: % Value 2021-2025
Table 46 LBN Brand Shares of Vitamins: % Value 2022-2025
Table 47 Forecast Sales of Vitamins by Category: Value 2025-2030
Table 48 Forecast Sales of Vitamins by Category: % Value Growth 2025-2030
DIETARY SUPPLEMENTS IN LATVIA
KEY DATA FINDINGS
2025 DEVELOPMENTS
Healthy value growth in 2025
Pharmacy chain Europatieka continues to lead, due to its affordable private label offering
Online sales increase by a quarter
PROSPECTS AND OPPORTUNITIES
Steady growth over forecast period
Technology and science drive innovation
Sustainability key area of focus
CATEGORY DATA
Table 49 Sales of Dietary Supplements by Category: Value 2020-2025
Table 50 Sales of Dietary Supplements by Category: % Value Growth 2020-2025
Table 51 Sales of Dietary Supplements by Positioning: % Value 2020-2025
Table 52 NBO Company Shares of Dietary Supplements: % Value 2021-2025
Table 53 LBN Brand Shares of Dietary Supplements: % Value 2022-2025
Table 54 Forecast Sales of Dietary Supplements by Category: Value 2025-2030
Table 55 Forecast Sales of Dietary Supplements by Category: % Value Growth 2025-2030
WEIGHT MANAGEMENT AND WELLBEING IN LATVIA
KEY DATA FINDINGS
2025 DEVELOPMENTS
Value and volume decline in 2025
Direct seller Herbalife continues to have commanding lead
Direct selling leads distribution
PROSPECTS AND OPPORTUNITIES
Further decline over forecast period
Continuing product innovation, supported by the digital space
Compliance, clearer labelling and greener positioning key priorities
CATEGORY DATA
Table 56 Sales of Weight Management and Wellbeing by Category: Value 2020-2025
Table 57 Sales of Weight Management and Wellbeing by Category: % Value Growth 2020-2025
Table 58 NBO Company Shares of Weight Management and Wellbeing: % Value 2021-2025
Table 59 LBN Brand Shares of Weight Management and Wellbeing: % Value 2022-2025
Table 60 Forecast Sales of Weight Management and Wellbeing by Category: Value 2025-2030
Table 61 Forecast Sales of Weight Management and Wellbeing by Category: % Value Growth 2025-2030
SPORTS NUTRITION IN LATVIA
KEY DATA FINDINGS
2025 DEVELOPMENTS
Best performer in 2025, in terms of value growth
Optimum Nutrition holds on to tight lead
Retail e-commerce dominates distribution
PROSPECTS AND OPPORTUNITIES
Continuing growth, but lower than over the review period
Continuing innovation as players look to keep ahead of the competition
Compliance and sustaniability key focus areas
CATEGORY DATA
Table 62 Sales of Sports Nutrition by Category: Value 2020-2025
Table 63 Sales of Sports Nutrition by Category: % Value Growth 2020-2025
Table 64 NBO Company Shares of Sports Nutrition: % Value 2021-2025
Table 65 LBN Brand Shares of Sports Nutrition: % Value 2022-2025
Table 66 Forecast Sales of Sports Nutrition by Category: Value 2025-2030
Table 67 Forecast Sales of Sports Nutrition by Category: % Value Growth 2025-2030
HERBAL/TRADITIONAL PRODUCTS IN LATVIA
KEY DATA FINDINGS
2025 DEVELOPMENTS
Muted performance in 2025
Local company Silvanols holds on to lead
Pharmacies continue to dominate
PROSPECTS AND OPPORTUNITIES
Modest performance over forecast period
Continuing innovation and differentiation
Tighter regulation will build consumer trust, while also leading to more consolidation
CATEGORY DATA
Table 68 Sales of Herbal/Traditional Products: Value 2020-2025
Table 69 Sales of Herbal/Traditional Products: % Value Growth 2020-2025
Table 70 NBO Company Shares of Herbal/Traditional Products: % Value 2021-2025
Table 71 LBN Brand Shares of Herbal/Traditional Products: % Value 2022-2025
Table 72 Forecast Sales of Herbal/Traditional Products: Value 2025-2030
Table 73 Forecast Sales of Herbal/Traditional Products: % Value Growth 2025-2030
PAEDIATRIC CONSUMER HEALTH IN LATVIA
KEY DATA FINDINGS
2025 DEVELOPMENTS
Ibuprofen registers highest value growth
Nurofen is the leading brand
Online sales increase significantly
PROSPECTS AND OPPORTUNITIES
Continuing value growth over forecast period
Continuing innovation over the forecast period
Growing focus on wellness
CATEGORY DATA
Table 74 Sales of Paediatric Consumer Health by Category: Value 2020-2025
Table 75 Sales of Paediatric Consumer Health by Category: % Value Growth 2020-2025
Table 76 Forecast Sales of Paediatric Consumer Health by Category: Value 2025-2030
Table 77 Forecast Sales of Paediatric Consumer Health by Category: % Value Growth 2025-2030

Search Inside Report

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us